ENTRY       D06351                      Drug
NAME        Yttrium Y 90 labetuzumab tetraxetan (USAN)
EFFICACY    Antineoplastic, Radioactive agent, Anti-CEA antibody
  TYPE      Antibody-drug conjugate
COMMENT     Radioimmunotherapy (RAIT) for CEA-expressing tumors in colorectal, pancreatic, lung, breast, ovarian, and medullary thyroid cancer
TARGET      CEACAM [HSA:1048 1084 1087 1088 1089 4680 634 90273] [KO:K06499]
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Cell adhesion molecules: Ig superfamiy
               CAMs
                CEACAM
                 D06351  Yttrium Y 90 labetuzumab tetraxetan (USAN)
DBLINKS     CAS: 501423-30-9
            PubChem: 47208008
///
